FN2 Earnings Intelligence
Pfizer Inc. ratios (quarterly)
Pfizer Inc. (PFE) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/30/2025 | 6/29/2025 | 9/28/2025 | 3/29/2026 | 6/28/2026 | 6/29/2026 est. | 9/28/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $1,430 | $1,638 | $1,343 | $1,703 | $976 | - | - |
| + Debt | $62,109 | $61,797 | $61,712 | $64,455 | $63,194 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $13,715 | $14,653 | $16,654 | $14,451 | $15,034 | $14,399.4 | $15,864.9 |
| % Growth | - | - | - | - | - | -1.7% | -4.7% |
| Gross Profit | $10,870 | $10,875 | $12,482 | $10,903 | $10,942 | - | - |
| % Margin | 79.3% | 74.2% | 74.9% | 75.4% | 72.8% | - | - |
| EBITDA | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| Net Income | $2,967 | $2,910 | $3,541 | $2,687 | -$248 | - | - |
| % Margin | 21.6% | 19.9% | 21.3% | 18.6% | -1.6% | - | - |
| Diluted EPS | $0.52 | $0.51 | $0.62 | $0.47 | -$0.04 | $0.68 | $0.73 |
| % Growth | - | - | - | - | - | 33.8% | 17.4% |
| Operating Cash Flow | $2,335 | - | - | $2,615 | - | - | - |
| CapEx | $564 | - | - | $436 | - | - | - |
| Free Cash Flow | $1,771 | - | - | $2,179 | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/30/2025 | 6/29/2025 | 9/28/2025 | 3/29/2026 | 6/28/2026 | 6/29/2026 est. | 9/28/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $13,715 | $14,653 | $16,654 | $14,451 | $15,034 | $14,399.4 | $15,864.9 |
| Gross Profit | $10,870 | $10,875 | $12,482 | $10,903 | $10,942 | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Net Income | $2,967 | $2,910 | $3,541 | $2,687 | -$248 | - | - |
| Diluted EPS | $0.52 | $0.51 | $0.62 | $0.47 | -$0.04 | $0.68 | $0.73 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/30/2025 | 6/29/2025 | 9/28/2025 | 3/29/2026 | 6/28/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1,430 | $1,638 | $1,343 | $1,703 | $976 |
| Short-term Debt | $4,470 | $4,295 | $4,303 | $3,890 | $2,699 |
| Long-term Debt | $57,639 | $57,502 | $57,409 | $60,565 | $60,495 |
| Total Debt | $62,109 | $61,797 | $61,712 | $64,455 | $63,194 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/30/2025 | 6/29/2025 | 9/28/2025 | 3/29/2026 | 6/28/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $2,335 | - | - | $2,615 | - |
| Capital Expenditure | $564 | - | - | $436 | - |
| Free Cash Flow | $1,771 | - | - | $2,179 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/30/2025 | 6/29/2025 | 9/28/2025 | 3/29/2026 | 6/28/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 79.3% | 74.2% | 74.9% | 75.4% | 72.8% |
| EBITDA Margin | - | - | - | - | - |
| Net Margin | 21.6% | 19.9% | 21.3% | 18.6% | -1.6% |
| FCF Margin | 12.9% | - | - | 15.1% | - |
| Diluted EPS Growth | - | - | - | - | - |
Get the PFE recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.